The global diabetic retinopathy drug market is anticipated to bolster at a robust growth rate to reach USD 705 Million by 2025. By End UsersOn the basis of end-users, the global diabetic retinopathy drug market is divided as ophthalmic clinics, hospitals, ambulatory surgical centers and others. Market Size and ForecastRegionally, North America dominates the global diabetic retinopathy drug market. Europe is the second largest diabetic retinopathy drug market behind North America. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles.

Source: The North Africa Journal March 18, 2021 12:47 UTC